Revvity, Inc.

RVTY

US7140461093

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:02 06/07/2024 am IST			5-day change	1st Jan Change
103.6 ^USD	+0.98%		-1.24%	-5.26%

27/06	Barclays Trims Price Target on Revvity to $115 From $116	MT
20/06	Bionano Genomics Says Revvity to Commercialize VIA Software	MT

PerkinElmer, Inc. Revises Earnings Guidance for the Fourth Quarter 2022

January 10, 2023 at 02:35 am IST

PerkinElmer, Inc. revised earnings guidance for the fourth quarter 2022. For the quarter, the company now expects its results to meet or exceed the guidance provided on November 8, 2022.

Latest news about Revvity, Inc.

Barclays Trims Price Target on Revvity to $115 From $116	27/06	MT
Bionano Genomics Says Revvity to Commercialize VIA Software	20/06	MT
Bionano Genomics, Inc. Announces Software Marketing Agreement with Revvity, Inc. for Newborn Sequencing Research	20/06	CI
GenKOre Announces Strategic Collaboration with Revvity to Develop Innovative Gene Therapy Treatments	18/06	CI
Transcript : Revvity, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 08:00 AM	10/06
Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM	14/05
TD Cowen Adjusts Price Target on Revvity to $130 From $123	30/04	MT
JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained	30/04	MT
Baird Adjusts Price Target on Revvity to $127 From $126	30/04	MT
Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating	30/04	MT
Nephron Adjusts Revvity's Price Target to $124 From $120	29/04	MT
Transcript : Revvity, Inc., Q1 2024 Earnings Call, Apr 29, 2024	29/04
Revvity beats quarterly estimates on demand for diagnostic equipment	29/04	RE
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance	29/04	MT
Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M	29/04	MT
Earnings Flash (RVTY) REVVITY Posts Q1 EPS $0.98, vs. Street Est of $0.94	29/04	MT
Revvity, Inc. Updates Earnings Guidance for the Full Year 2024	29/04	CI
Revvity, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	26/04	CI
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	25/04	CI
Declaration of Voting Results by Revvity, Inc	25/04	CI
Revvity Unveils A New Era of Automated Tuberculosis Testing	24/04	CI
Bernstein Adjusts Price Target on Revvity to $125 From $126	22/04	MT
Baird Adjusts Price Target on Revvity to $126 From $123	22/04	MT
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	03/04	MT

Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).

Sector

Advanced Medical Equipment & Technology

Calendar

19/07/2024 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Revvity, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

103.6 USD

Average target price

124 USD

Spread / Average Target

+19.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
REVVITY, INC.	-5.26%	1.28TCr
THERMO FISHER SCIENTIFIC	+1.75%	21TCr
DANAHER CORPORATION	+3.42%	18TCr
INTUITIVE SURGICAL, INC.	+31.54%	16TCr
BOSTON SCIENTIFIC CORPORATION	+32.16%	11TCr
SIEMENS HEALTHINEERS AG	+1.71%	6.46TCr
EDWARDS LIFESCIENCES CORPORATION	+21.08%	5.56TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.61%	4.76TCr
AGILENT TECHNOLOGIES, INC.	-9.11%	3.69TCr
GE HEALTHCARE TECHNOLOGIES INC.	-0.34%	3.52TCr

Other Advanced Medical Equipment & Technology

Revvity, Inc.

Equities

RVTY

US7140461093

Advanced Medical Equipment & Technology

PerkinElmer, Inc. Revises Earnings Guidance for the Fourth Quarter 2022

Latest news about Revvity, Inc.

Chart Revvity, Inc.

Company Profile

Income Statement Evolution

Ratings for Revvity, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology